Families who already keep a glucagon rescue product at home still ask whether a ready-to-use pen is different from older kits that needed mixing, or from a nasal powder device. Zegalogue (dasiglucagon) is a glucagon-receptor agonist peptide analog supplied as a clear liquid in a single-dose autoinjector or prefilled syringe for severe hypoglycemia in people with diabetes in the labeled age group. The everyday takeaway is practice who will give it, call for emergency help right after use, and plan oral carbs once the person can swallow—not treat the device as a substitute for 911.
A ready liquid glucagon analog, not a DIY mix kit
UniProt lists proglucagon (P01275), the precursor that includes the 29-amino-acid hormone glucagon. Dasiglucagon is engineered to activate the same receptor pathway so the liver can release stored sugar during a severe low. Unlike some legacy emergency kits that required reconstitution under stress, Zegalogue ships as a ready solution in a single-use device. That still does not remove the need for someone nearby who recognizes severe hypoglycemia and knows where the protective case is.
The American Diabetes Association’s hypoglycemia guidance stresses that severe lows can mean confusion, seizures, or unconsciousness—situations where the person cannot safely self-treat with food alone. Keep the device where caregivers, roommates, or coworkers expect it, and review the Instructions for Use before a crisis, not during one.
After the shot: emergency help, carbs, and a second device
The DailyMed label tells caregivers to call for emergency assistance immediately after giving Zegalogue, even if the person wakes up. If there is no response after about 15 minutes, another dose from a new device may be given while waiting for help. When the person can swallow, give oral carbohydrates to rebuild liver glycogen and lower the chance of another low. Turn the person on their side if vomiting is possible. Do not reuse a spent device.
Label warnings also flag pheochromocytoma and insulinoma contraindications, plus the possibility of allergic reactions. Common effects include nausea, vomiting, headache, and injection-site discomfort. Storage rules on the case matter: follow refrigeration or room-temperature windows printed for your lot, and never use a discolored or particulate solution.
Questions that change what you notice next. Ask which rescue product is actually prescribed (ready liquid dasiglucagon versus nasal powder versus older mix kits), who in the household or workplace has practiced the device, where the spare case lives for travel, and what counts as “call now” versus waiting for a second device. Write one line for babysitters or camp staff: give the rescue, call emergency help, offer carbs only when safe to swallow.
Not medical advice.
Sources
- DailyMed: Zegalogue (dasiglucagon) prescribing information
- American Diabetes Association: Hypoglycemia (low blood glucose)
- MedlinePlus: Hypoglycemia
- UniProt: Proglucagon / glucagon (P01275)
Related reading
- Nasal glucagon for coworkers in a severe low
- School diabetes plans and glucagon-trained staff
- Home sharps containers for used peptide pens
By The Everyday Brief. AI-assisted drafting with human editorial review. Sources fetched 2026-10-11 PT. Not medical advice.